大麻衍生物及其合成类型用于治疗耐药性:系统性审查和元分析
Ana Luiza Cabrera Martimbianco1, Roberta Borges Silva2, Carolina de Oliveira Cruz Latorraca3
1Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil; Universidade Metropolitana de Santos (Unimes), Santos, SP, Brazil.
Epilepsy research
|April 23, 2025
概括
大麻 (CBD) 可能会减少耐药性的月经发作,但可能会增加严重的不良事件. 需要更多的研究来了解大麻素对这种情况的影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 临床试验 临床试验
背景情况:
- 包括大麻二醇 (CBD) 在内的大麻三衍生物正在研究治疗耐火性.
- 研究CBD和相关化合物为难以治疗的病病例提供了潜在的替代方案.
研究的目的:
- 系统地评估大麻衍生物在治疗耐火性的有效性和安全性.
- 评估CBD对患者发作频率和不良事件的影响.
主要方法:
- 在多个数据库和注册表中进行了全面的文献搜索.
- 包括随机对照试验 (RCT) 和使用Cochrane工具评估偏差风险.
- 使用GRADE方法评估证据的确定性.
主要成果:
- 分析了七个RCT,涉及20毫克/公斤/天和10毫克/公斤/天的cannabidiol (CBD).
- CBD可能增加了参与者实现每月发作减少≥50%的比例 (中等确定性).
- 严重的不良事件可能随着CBD20 mg/kg/day (中等确定性) 和可能随着10 mg/kg/day (低确定性) 的增加.
结论:
- 关于大麻素对耐火性的大多数结果的整体影响,仍然存在不确定性.
- 其他大麻素干预措施的证据显示确定性低至非常低.
- 未来的RCT对于更清楚地了解难治性中大麻素的治疗潜力至关重要.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
259
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
259
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
130
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
130
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
184
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
184
Antiepileptic Drugs: Glutamate Antagonists
246
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
246
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
184
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
184
Arteries of the Lower Limbs
166
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
166


